AstraZeneca

‘It Will Never Be Licensed In The US’ – Analyst Warns AstraZeneca Vaccine Efficacy “Embellished”

AstraZeneca’s announcement that its adenovirus-vector vaccine is roughly 70% effective (which followed an announcement claiming the vaccine is safe and effective in the elderly) failed to impress investors, as Astrazeneca shares tumbled on the news in premarket. But AZ shares took a second leg lower on Monday when a health-care analyst dropped some damning commentary…

AstraZeneca COVID-19 Vaccine 70% Effective, UK Expects Millions Of Doses By Year’s End

Continuing the pattern of leading COVID-19 vaccine projects releasing their Phase 3 trial results on Monday, AstraZeneca has just revealed that its vaccine – which, unlike the Moderna and Pfizer vaccines, relies on the more traditional adenovirus vector approach – is 70% effective at preventing the coronavirus. The results follow last week’s release of the…

CDC Asks Americans Not To Travel For Thanksgiving; AstraZeneca Vaccine Elicits Promising Results: Live Updates

Summary: CDC warns Americans not to travel for Thanksgiving Moderna CEO says vaccines can be made faster Trump tweets on vaccines AZ confirms vaccine safe and effective in older patients Global cases top 56 million World reports more than 600k new cases Minnesota governor latest to close indoor dining Finland faces rapid spike Tokyo imposes…